A bacterial injection system controlled by light

Molecular principle of the LITESEC system. In the dark (left), a T3SS component, which is necessary for the injection (red), is anchored to the bacterial membrane.

Credit: Max Planck Institute for terrestrial Microbiology/Diepold

By coupling a bacterial injection system with a light-controlled molecular switch, scientists are able to inject proteins into eukaryontic cells

When bacteria such as Salmonella or Yersinia cause fever, diarrhoea or abdominal pain, tiny “injection needles” are at work: their type 3 secretion system, or T3SS for short, shoots bacterial virulence proteins directly into the eukaryotic host cells. Researchers have thought of using bacterial injection devices to introduce proteins into eukaryotic cells. A Max Planck research team has now succeeded in controlling the injection system optogenetically, i.e. with light. In the future this will enable to use the system in biotechnological or medical applications.

The T3SS is essential for virulence in many important human pathogens, including Salmonella, Shigella, and pathogenic Escherichia coli, that cause several millions of deaths per year. It is also important in hospital infections, for example by Pseudomonas aeruginosa, where presence of a functional T3SS is associated with higher mortality in animal models and increased antibiotic resistance, severe disease, and a bad prognosis in infected humans.

Consequently, the T3SS is considered a central target for potential therapeutics that could impair its function and prevent infections. On the other hand, hijacking this bacterial system would offer the chance for controlled protein delivery to host cells through the T3SS, like in a trojanic horse. Protein injection through T3SS is fast and efficient: a single injectisome can transfer several thousand effector proteins in few seconds.

However, as powerful as the T3SS injection system is, it is far from accurate – much to the disappointment of the researchers. „As soon as a T3SS contacts any host cell, it fires its load immediately. This is unfavourable for applications in biotechnology or medicine, where we want to target specific cell types, for example in tumour therapy“, says Andreas Diepold, Research group leader at the Max-Planck-Institute for Terrestrial Microbiology in Marburg.

Protein injection via on/off switch

But now Andreas Diepold and his team have come a big step closer to this goal: they succeeded in controlling the T3SS injectisome using a molecular light switch. This will enable scientists to inject proteins into eukaryotic cells at a precise time and place. During my postdoctoral fellowship in Oxford, I discovered that some parts of the T3SS are dynamic“, Andreas Diepold recalls. „They are constantly exchanged between this apparatus and the interior of the cell.“ The scientist applied his findings to the young research field of optogenetics. The principle of this technique is that protein interactions can be controlled with millisecond speed by changing their conformation when stimulated with light of specific wavelengths, thus allowing a fast and specific control of defined molecular processes in biological systems.

Doctoral fellow Florian Lindner coupled the dynamic T3SS component with one part of this optogenetic interaction switch, while its other part was anchored to the bacterial membrane. By exposing bacteria and host cells to blue light, the availability of the T3SS components and consequently the function of the T3SS could be switched on and off.

Applying LITESEC to tumor research

Since the system is flexible in regard to which kind of proteins are injected, it can be used in many ways. In a collaboration with Thorsten Stiewe from the Philipps University in Marburg, the research group used the new system to attack and kill cultured tumour cells. The group now plans to use this technique for future basic research and for the development of further applications.

Learn more: Light drives injection

Go deeper with Bing News on:

Bacterial injection system

Finally, a Shot to Prevent Lyme Disease Could Be on Its Way
on August 15, 2021 at 5:00 pm
Lyme-carrying ticks are a bigger threat than ever. A promising new antibody treatment looks to stop infection—even after a tick bite.
CDC Grand Rounds: Preventing Unsafe Injection Practices in the U.S. Health-care System
on August 13, 2021 at 4:59 pm
Traditionally, injection safety has been recognized as ... the other 28 represented outbreaks of bacterial infections, primarily invasive bloodstream infections. Approximately 90% of these known ...
Is It Safe To Use Qwo, The New FDA-Approved Cellulite Treatment?
on August 11, 2021 at 6:45 am
What if you could get rid of cellulite in a few months, with no lifestyle changes and no invasive procedures? That’s the promise of Qwo, the first and only injectable treatment for cellulite approved ...
Lyme disease protection: No vaccine yet, but an antibody shot could soon provide a season of immunity
on August 6, 2021 at 2:37 pm
Lyme disease has become an insidious epidemic in the United States. Caused by bacteria transmitted through the bite of an infected tick, it can lead to heart problems, meningitis or arthritis if left ...
Lyme disease protection: No vaccine yet, but an antibody shot could soon provide a season of immunity
on August 4, 2021 at 1:37 pm
Scientists, doctors and ecologists have worked for decades to slow the spread of Lyme and the blacklegged, or deer, ticks that carry the disease-causing bacteria. However, the ticks’ range ...

Go deeper with Google Headlines on:

Bacterial injection system

Disparate regulation of IMD signaling drives sex differences in infection pathology in Drosophila melanogaster - pnas.org
August 10, 2021
Meningitis vs. encephalitis: Links, differences, and more - Medical News Today
July 29, 2021
Scratch From Dog: Health Risks, Treatment, and Prevention - Healthline
July 28, 2021
What to Know About the Meningitis B Vaccine - Healthline
August 16, 2021
Bacteria adapt syringe apparatus to changing conditions: Study shows how pathogenic bacteria can adapt to varying conditions of the digestive tract - Science Daily
March 15, 2021

Go deeper with Bing News on:

Optogenetic injection system

Stem Cell Therapy Repairs Injured Tendons
on August 17, 2021 at 5:06 am
The hypothesis was that SVF injection would improve tendon healing ... on an animal model employing a mechanical fat breakdown system (Rigenera Technology, Rigenera ®, HBW, Turin, Italy) as ...
Study suggests gene therapy could prevent vision loss in patients with retinal disease or injury
on August 11, 2021 at 4:56 am
Investigators uncovered evidence that CaMKII could prove to be a desirable therapeutic target for vision preservation in conditions that damage the axons and somas of retinal ganglion cells.
Serious adverse reaction halts gene therapy for diabetic macular edema
on August 10, 2021 at 12:48 pm
Adverum Biotechnologies announced that they are no longer developing ADVM-022 for diabetic macular edema (DME) after a dose-limiting toxicity was observed at the 6 x 1011 vg/eye high dose in the phase ...
Rapid generation of maternal mutants via oocyte transgenic expression of CRISPR-Cas9 and sgRNAs in zebrafish
on August 9, 2021 at 12:16 am
Therefore, a rapid and straightforward system to inactivate genes in the oocyte may break ... cas9 in the oocytes and tested its application in routine gene inactivation by injection of single guide ...
Retinal waves prime visual motion detection by simulating future optic flow
on July 30, 2021 at 4:57 am
optogenetic, and genetic strategies to identify the retinal circuitry underlying the propagation bias. Finally, to evaluate the role of directional retinal waves in visual system development, we used ...